Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Garren Hideki. Director active across 2 companies, notably Prothena CORP Public Ltd Co. In total, 13 reports have been recorded. Breakdown: 1 buy · 0 sell. History available since 6 July 2022. The latest transaction was disclosed on 13 September 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Garren Hideki
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8,000 shares@ US$24.9014.2% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-013840:0
13 of 13 declarations
About Garren Hideki
Garren Hideki has 13 filings in total. In the recent filings covered, the most common transaction type is option exercise, with activity in Prothena CORP Public Ltd Co and Coya Therapeutics, Inc., between 2022-07-08 and 2023-09-13. The buy and sell amounts are both EUR 0 in this recent sample.